Third Rock Ventures II, L.P.
Insider CIK 1488495 · MYOK 10% owner · BPMC 10% owner · SAGE 10% owner · ALNA 10% owner · RVMD 10% owner · GBT 10% owner · JNCE 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JNCE Jounce Therapeutics, Inc. | J Other | 2021-09-15 | 2021-09-17 | 1,750,000 | — | $0 | 2,697,829 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | J Other | 2021-06-10 | 2021-06-14 | 1,500,000 | — | $0 | 4,447,829 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2021-06-04 | 2021-06-07 | 164,996 | $30.23 | $4.99M | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2021-06-03 | 2021-06-07 | 378,117 | $30.20 | $11.42M | 164,996 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2021-05-26 | 2021-05-27 | 1,231,204 | $30.53 | $37.59M | 543,113 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-05-25 | 2021-05-27 | 552,520 | $8.00 | $4.42M | 5,947,829 | SEC↗ |
| RVMD Revolution Medicines, Inc. | S Sale | 2021-05-25 | 2021-05-27 | 135,000 | $30.93 | $4.18M | 1,774,317 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | J Other | 2021-03-11 | 2021-03-15 | 1,250,000 | — | $0 | 6,500,349 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-03 | 1,450,000 | $11.75 | $17.04M | 7,750,349 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-11-19 | 2020-11-23 | 15,000 | $7.01 | $105.2K | 9,200,349 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | S Sale | 2020-11-17 | 2020-11-19 | 15,000 | $7.25 | $108.8K | 9,215,349 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | J Other | 2020-11-11 | 2020-11-13 | 1,000,000 | — | $0 | 9,230,349 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion deriv | 2020-02-18 | 2020-02-18 | 342,505 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion deriv | 2020-02-18 | 2020-02-18 | 8,220,641 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion deriv | 2020-02-18 | 2020-02-18 | 49,879 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion deriv | 2020-02-18 | 2020-02-18 | 1,909,317 | — | $0 | 0 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion | 2020-02-18 | 2020-02-18 | 8,613,025 | — | $0 | 9,024,031 | SEC↗ |
| RVMD Revolution Medicines, Inc. | C Conversion | 2020-02-18 | 2020-02-18 | 1,909,317 | — | $0 | 1,909,317 | SEC↗ |
| MYOK MyoKardia Inc | J Other | 2018-03-07 | 2018-03-07 | 2,000,000 | — | $0 | 885,104 | SEC↗ |
| MYOK MyoKardia Inc | J Other | 2017-12-06 | 2017-12-08 | 2,000,000 | — | $0 | 2,885,104 | SEC↗ |
| ALNA Allena Pharmaceuticals, In | C Conversion deriv | 2017-11-06 | 2017-11-06 | 6,122,448 | — | $0 | 0 | SEC↗ |
| ALNA Allena Pharmaceuticals, In | C Conversion deriv | 2017-11-06 | 2017-11-06 | 4,629,630 | — | $0 | 0 | SEC↗ |
| ALNA Allena Pharmaceuticals, In | P Buy | 2017-11-06 | 2017-11-06 | 215,000 | $14.00 | $3.01M | 2,790,964 | SEC↗ |
| ALNA Allena Pharmaceuticals, In | C Conversion | 2017-11-06 | 2017-11-06 | 2,575,964 | — | $0 | 2,575,964 | SEC↗ |
| MYOK MyoKardia Inc | J Other | 2017-09-28 | 2018-02-13 | 2,000,000 | — | $0 | 4,885,104 | SEC↗ |
| MYOK MyoKardia Inc | J Other | 2017-09-28 | 2017-09-29 | 2,000,000 | — | $0 | 4,885,104 | SEC↗ |
| MYOK MyoKardia Inc | S Sale | 2017-09-26 | 2017-09-27 | 400,000 | $43.00 | $17.20M | 6,885,104 | SEC↗ |
| MYOK MyoKardia Inc | S Sale | 2017-09-25 | 2017-09-27 | 201,400 | $43.00 | $8.66M | 7,285,104 | SEC↗ |
| MYOK MyoKardia Inc | S Sale | 2017-09-11 | 2017-09-12 | 20,000 | $44.25 | $885.0K | 57,651 | SEC↗ |
| MYOK MyoKardia Inc | S Sale | 2017-09-08 | 2017-09-12 | 200,350 | $41.00 | $8.21M | 7,487,404 | SEC↗ |
| MYOK MyoKardia Inc | S Sale | 2017-09-08 | 2017-09-12 | 900 | $42.39 | $38.2K | 7,486,504 | SEC↗ |
| GBT Global Blood Therapeutics, | J Other | 2017-06-14 | 2017-06-16 | 1,000,000 | — | $0 | 2,475,191 | SEC↗ |
| GBT Global Blood Therapeutics, | J Other | 2017-05-17 | 2017-05-19 | 1,000,000 | — | $0 | 3,475,191 | SEC↗ |
| GBT Global Blood Therapeutics, | G Gift | 2017-04-18 | 2017-05-19 | 1,708 | — | $0 | 163,996 | SEC↗ |
| GBT Global Blood Therapeutics, | G Gift | 2017-04-11 | 2017-05-19 | 50,000 | — | $0 | 165,704 | SEC↗ |
| GBT Global Blood Therapeutics, | J Other | 2017-04-06 | 2017-04-06 | 2,000,000 | — | $0 | 4,475,191 | SEC↗ |
| MYOK MyoKardia Inc | J Other | 2017-03-30 | 2017-04-03 | 850,000 | — | $0 | 7,687,754 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-03-02 | 2017-03-06 | 10,900 | $28.73 | $313.2K | 146,208 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-03-02 | 2017-03-06 | 7,279 | $27.69 | $201.6K | 157,108 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-03-02 | 2017-03-06 | 1,000,000 | $25.50 | $25.50M | 285,713 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-03-02 | 2017-03-06 | 1,000,000 | $25.50 | $25.50M | 6,475,191 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2017-03-02 | 2017-03-06 | 27,115 | $26.95 | $730.7K | 164,387 | SEC↗ |
| BPMC Blueprint Medicines Corp | J Other | 2017-02-27 | 2017-02-28 | 1,000,000 | — | $0 | 3,453,753 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2017-02-07 | 2017-02-09 | 1,000,000 | $35.28 | $35.28M | 4,453,753 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion deriv | 2017-02-01 | 2017-02-03 | 11,250,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion deriv | 2017-02-01 | 2017-02-03 | 35,750,000 | — | $0 | 0 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion | 2017-02-01 | 2017-02-03 | 9,688,344 | — | $0 | 10,230,349 | SEC↗ |
| JNCE Jounce Therapeutics, Inc. | C Conversion | 2017-02-01 | 2017-02-03 | 3,048,780 | — | $0 | 3,048,780 | SEC↗ |
| GBT Global Blood Therapeutics, | J Other | 2016-12-14 | 2016-12-16 | 2,000,000 | — | $0 | 7,475,191 | SEC↗ |
| MYOK MyoKardia Inc | J Other | 2016-11-29 | 2016-12-01 | 850,000 | — | $0 | 8,537,754 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2016-11-14 | 2016-11-16 | 1,000,000 | $19.36 | $19.36M | 9,475,191 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2016-11-14 | 2016-11-16 | 1,000,000 | $19.36 | $19.36M | 1,285,713 | SEC↗ |
| GBT Global Blood Therapeutics, | J Other | 2016-11-03 | 2016-11-07 | 2,000,000 | — | $0 | 10,475,191 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2016-08-19 | 2016-08-19 | 1,000,000 | — | $0 | 2,892,916 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | S Sale | 2016-05-16 | 2016-05-18 | 850,000 | $31.25 | $26.56M | 3,892,916 | SEC↗ |
| BPMC Blueprint Medicines Corp | J Other | 2016-04-14 | 2016-04-15 | 1,200,000 | — | $0 | 5,453,753 | SEC↗ |
| BPMC Blueprint Medicines Corp | J Other | 2015-11-18 | 2015-11-18 | 220,387 | — | $0 | 220,387 | SEC↗ |
| BPMC Blueprint Medicines Corp | J Other | 2015-11-18 | 2015-11-18 | 739,306 | — | $0 | 6,653,753 | SEC↗ |
| BPMC Blueprint Medicines Corp | J Other | 2015-11-18 | 2015-11-18 | 220,387 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | J Other | 2015-11-18 | 2015-11-18 | 40,290 | — | $0 | 40,290 | SEC↗ |
| BPMC Blueprint Medicines Corp | J Other | 2015-11-18 | 2015-11-18 | 40,290 | — | $0 | 40,290 | SEC↗ |
| BPMC Blueprint Medicines Corp | J Other | 2015-11-18 | 2015-11-18 | 40,290 | — | $0 | 40,290 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-11-12 | 2015-11-13 | 109,832 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-11-12 | 2015-11-13 | 1,700,000 | — | $0 | 4,742,916 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-11-12 | 2015-11-13 | 109,832 | — | $0 | 109,832 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-11-12 | 2015-11-13 | 15,986 | — | $0 | 65,226 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-11-12 | 2015-11-13 | 15,986 | — | $0 | 65,227 | SEC↗ |
| MYOK MyoKardia Inc | C Conversion deriv | 2015-11-03 | 2015-11-05 | 5,500,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia Inc | C Conversion deriv | 2015-11-03 | 2015-11-05 | 32,500,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia Inc | C Conversion | 2015-11-03 | 2015-11-05 | 8,843,537 | — | $0 | 9,387,754 | SEC↗ |
| MYOK MyoKardia Inc | C Conversion | 2015-11-03 | 2015-11-05 | 1,496,598 | — | $0 | 1,496,598 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-08-18 | 2015-08-18 | 150,546 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-08-18 | 2015-08-18 | 150,546 | — | $0 | 150,546 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-08-18 | 2015-08-18 | 2,330,157 | — | $0 | 6,442,916 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-08-18 | 2015-08-18 | 21,910 | — | $0 | 49,241 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-08-18 | 2015-08-18 | 21,910 | — | $0 | 49,240 | SEC↗ |
| GBT Global Blood Therapeutics, | C Conversion deriv | 2015-08-17 | 2015-08-19 | 41,663,168 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | C Conversion | 2015-08-17 | 2015-08-19 | 11,903,763 | — | $0 | 12,475,191 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-06-19 | 2015-06-22 | 64,607 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-06-19 | 2015-06-22 | 9,403 | — | $0 | 27,331 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-06-19 | 2015-06-22 | 9,402 | — | $0 | 27,330 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-06-19 | 2015-06-22 | 64,607 | — | $0 | 64,607 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-06-19 | 2015-06-22 | 1,000,000 | — | $0 | 8,773,073 | SEC↗ |
| BPMC Blueprint Medicines Corp | C Conversion deriv | 2015-05-05 | 2015-05-12 | 1,328,502 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | C Conversion deriv | 2015-05-05 | 2015-05-12 | 7,833,333 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | C Conversion deriv | 2015-05-05 | 2015-05-12 | 30,000,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | C Conversion | 2015-05-05 | 2015-05-12 | 5,454,545 | — | $0 | 5,727,272 | SEC↗ |
| BPMC Blueprint Medicines Corp | C Conversion | 2015-05-05 | 2015-05-12 | 241,545 | — | $0 | 7,393,059 | SEC↗ |
| BPMC Blueprint Medicines Corp | C Conversion | 2015-05-05 | 2015-05-12 | 1,424,242 | — | $0 | 7,151,514 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-01-27 | 2015-01-28 | 1,255,177 | — | $0 | 9,773,073 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-01-27 | 2015-01-28 | 81,094 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-01-27 | 2015-01-28 | 81,094 | — | $0 | 81,094 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-01-16 | 2015-01-20 | 652,758 | — | $0 | 11,028,250 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-01-16 | 2015-01-20 | 42,173 | — | $0 | 42,173 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | J Other | 2015-01-16 | 2015-01-20 | 42,173 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion deriv | 2014-07-23 | 2014-07-23 | 32,500,000 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion deriv | 2014-07-23 | 2014-07-23 | 2,499,999 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion deriv | 2014-07-23 | 2014-07-23 | 295,194 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion | 2014-07-23 | 2014-07-23 | 793,650 | — | $0 | 11,587,296 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion | 2014-07-23 | 2014-07-23 | 93,712 | — | $0 | 11,681,008 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | C Conversion | 2014-07-23 | 2014-07-23 | 10,317,457 | — | $0 | 10,793,646 | SEC↗ |